Insider Trading disclosures for MiNK Therapeutics Inc

The latest disclosure was made by Robert Peter Kadlec in MiNK Therapeutics Inc where a trade of 1,536 Common Stock done at an average price of $8.8 was reported to US exchanges on March 3, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Robert Peter Kadlec	Director	Grant, award, or other acquisition of securities at price $ 8.79 per share.	03 Mar 2025	1,536	2,764	-	8.8	13,501	Common Stock
Peter Behner	Director	Grant, award, or other acquisition of securities at price $ 8.79 per share.	03 Mar 2025	1,849	15,209	-	8.8	16,253	Common Stock
Barbara Ryan	Director	Grant, award, or other acquisition of securities at price $ 8.79 per share.	03 Mar 2025	2,019	17,048	-	8.8	17,747	Common Stock
Brian J. Corvese	Director	Grant, award, or other acquisition of securities at price $ 8.79 per share.	03 Mar 2025	2,033	44,657	-	8.8	17,870	Common Stock
Ulf Wiinberg	Director	Grant, award, or other acquisition of securities at price $ 8.79 per share.	03 Mar 2025	1,593	16,007	-	8.8	14,002	Common Stock
Peter Behner	Director	Grant, award, or other acquisition of securities at price $ 0.73 per share.	01 Dec 2024	20,987	133,634	-	0.7	15,321	Common Stock
Barbara Ryan	Director	Grant, award, or other acquisition of securities at price $ 0.73 per share.	01 Dec 2024	24,229	150,336	-	0.7	17,687	Common Stock
Brian J. Corvese	Director	Grant, award, or other acquisition of securities at price $ 0.73 per share.	01 Dec 2024	24,400	426,283	-	0.7	17,812	Common Stock
Ulf Wiinberg	Director	Grant, award, or other acquisition of securities at price $ 0.73 per share.	01 Dec 2024	20,476	144,181	-	0.7	14,947	Common Stock
Robert Kadlec	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Oct 2024	41,745	41,745	-		-	Stock Option
Robert Kadlec	Director	Grant, award, or other acquisition of securities at price $ 0.73 per share.	30 Oct 2024	12,286	12,286	-	0.7	8,969	Common Stock
Ulf Wiinberg	Director	Grant, award, or other acquisition of securities at price $ 0.82 per share.	03 Sep 2024	18,295	123,705	-	0.8	15,002	Common Stock
Brian J. Corvese	Director	Grant, award, or other acquisition of securities at price $ 0.82 per share.	03 Sep 2024	21,802	405,296	-	0.8	17,878	Common Stock
Peter Behner	Director	Grant, award, or other acquisition of securities at price $ 0.82 per share.	03 Sep 2024	18,753	109,234	-	0.8	15,377	Common Stock
Barbara Ryan	Director	Grant, award, or other acquisition of securities at price $ 0.82 per share.	03 Sep 2024	21,649	126,107	-	0.8	17,752	Common Stock
Peter Behner	Director	Grant, award, or other acquisition of securities at price $ 0.99 per share.	03 Jun 2024	15,454	90,481	-	1.0	15,299	Common Stock
Barbara Ryan	Director	Grant, award, or other acquisition of securities at price $ 0.99 per share.	03 Jun 2024	17,841	104,458	-	1.0	17,663	Common Stock
Brian J. Corvese	Director	Grant, award, or other acquisition of securities at price $ 0.99 per share.	03 Jun 2024	17,967	383,494	-	1.0	17,787	Common Stock
Ulf Wiinberg	Director	Grant, award, or other acquisition of securities at price $ 0.99 per share.	03 Jun 2024	15,077	105,410	-	1.0	14,926	Common Stock
Brian J. Corvese	Director	Grant, award, or other acquisition of securities at price $ 0.95 per share.	01 Mar 2024	18,816	365,527	-	0.9	17,875	Common Stock
Ulf Wiinberg	Director	Grant, award, or other acquisition of securities at price $ 0.95 per share.	01 Mar 2024	15,790	90,333	-	1.0	15,001	Common Stock
Barbara Ryan	Director	Grant, award, or other acquisition of securities at price $ 0.95 per share.	01 Mar 2024	18,685	86,617	-	1.0	17,751	Common Stock
Peter Behner	Director	Grant, award, or other acquisition of securities at price $ 0.95 per share.	01 Mar 2024	16,185	75,027	-	1.0	15,376	Common Stock
Buell S. Jennifer	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jan 2024	500,000	500,000	-		-	Stock Option
S. Buell Jennifer	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jan 2024	660,919	660,919	-		-	Stock Option
Marc van Dijk	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jan 2024	15,000	15,000	-		-	Stock Option
Marc van Dijk	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jan 2024	171,078	171,078	-		-	Stock Option
Barbara Ryan	Director	Grant, award, or other acquisition of securities at price $ 1.04 per share.	01 Dec 2023	17,068	67,932	-	1.0	17,751	Common Stock
Corvese J. Brian	Director	Grant, award, or other acquisition of securities at price $ 1.04 per share.	01 Dec 2023	17,188	346,711	-	1.0	17,876	Common Stock
Ulf Wiinberg	Director	Grant, award, or other acquisition of securities at price $ 1.04 per share.	01 Dec 2023	14,424	74,543	-	1.0	15,001	Common Stock
Behner Peter	Director	Grant, award, or other acquisition of securities at price $ 1.04 per share.	01 Dec 2023	14,784	58,842	-	1.0	15,375	Common Stock
Garo H. Armen	Director	Purchase of securities on an exchange or from another person at price $ 0.95 per share.	02 May 2023	100,000	1,978,010	-	0.9	94,850	Common Stock
Ulf Wiinberg	Director	Grant, award, or other acquisition of securities at price $ 2.09 per share.	01 Mar 2023	6,699	42,751	-	2.1	14,001	Common Stock
Brian J. Corvese	Director	Grant, award, or other acquisition of securities at price $ 2.09 per share.	01 Mar 2023	8,553	307,348	-	2.1	17,876	Common Stock
Barbara Ryan	Director	Grant, award, or other acquisition of securities at price $ 2.09 per share.	01 Mar 2023	8,493	28,844	-	2.1	17,750	Common Stock
Peter Behner	Director	Grant, award, or other acquisition of securities at price $ 2.09 per share.	01 Mar 2023	7,357	24,985	-	2.1	15,376	Common Stock
John Baldoni	Director	Grant, award, or other acquisition of securities at price $ 2.09 per share.	01 Mar 2023	6,878	23,360	-	2.1	14,375	Common stock
Garo H. Armen	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jan 2023	200,000	200,000	-		-	Stock Option
Marc van Dijk	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jan 2023	15,000	15,000	-		-	Stock Option
Jennifer S. Buell	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jan 2023	500,000	500,000	-		-	Stock Option
Jennifer S. Buell	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 2.32 per share.	09 Jan 2023	171,990	380,715	-	2.3	399,017	Common Stock
Marc van Dijk	Chief Scientific Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.32 per share.	09 Jan 2023	24,265	27,363	-	2.3	56,295	Common Stock
Marc van Dijk	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 2.32 per share.	09 Jan 2023	51,628	51,628	-	2.3	119,777	Common Stock
Brian J. Corvese	Director	Grant, award, or other acquisition of securities at price $ 2.61 per share.	01 Dec 2022	6,849	298,795	-	2.6	17,876	Common Stock
Ulf Wiinberg	Director	Grant, award, or other acquisition of securities at price $ 2.61 per share.	01 Dec 2022	5,364	36,052	-	2.6	14,000	Common Stock
Barbara Ryan	Director	Grant, award, or other acquisition of securities at price $ 2.61 per share.	01 Dec 2022	6,801	20,351	-	2.6	17,751	Common Stock
Peter Behner	Director	Grant, award, or other acquisition of securities at price $ 2.61 per share.	01 Dec 2022	5,891	17,628	-	2.6	15,376	Common Stock
John Baldoni	Director	Grant, award, or other acquisition of securities at price $ 2.61 per share.	01 Dec 2022	5,508	16,482	-	2.6	14,376	Common stock
John Baldoni	Director	Grant, award, or other acquisition of securities at price $ 2.62 per share.	15 Sep 2022	10,974	10,974	-	2.6	28,752	Common stock
Peter Behner	Director	Grant, award, or other acquisition of securities at price $ 2.62 per share.	15 Sep 2022	11,737	11,737	-	2.6	30,751	Common Stock

Showing 1 to 50 of 62 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

46.77% Fall from 52W High

Insider Trading disclosures for MiNK Therapeutics Inc

The latest disclosure was made by Robert Peter Kadlec in MiNK Therapeutics Inc where a trade of 1,536 Common Stock done at an average price of $8.8 was reported to US exchanges on March 3, 2025.

Screeners based on Insider Trading and SAST parameters